避孕藥市場：按類型、途徑、年齡層、分銷管道和地區。

2023年全球避孕藥具市場價值為197.4億美元，預計到2031年將達到524.1億美元，2024年至2031年年複合成長率為13%。

圖 1. 2024 年按地區分類的全球市場佔有率(%)

過去幾十年來，全球避孕藥市場經歷了穩定成長。避孕藥通常稱為避孕藥，含有女性荷爾蒙雌激素和黃體酮的合成版本。口服它可以透過抑制排卵和改變子宮頸黏液和子宮內膜來預防懷孕。人們對計劃生育態度的轉變、對意外懷孕的日益關注、性健康意識的提高以及避孕藥具監管規範的加強，正在推動全球避孕藥具的需求。此外，女性勞動參與率的提高和延遲懷孕進一步提高了口服避孕藥的接受度。

市場動態：

識字率的提高和婦女賦權是推動避孕藥具市場向前發展的關鍵因素。隨著人們對婦女生殖健康和權利的認知不斷提高，人們普遍接受避孕藥來延遲或計劃懷孕。快速的都市化、生活方式的改變以及獲得現代醫療保健的便利性正在導致更多女性選擇口服避孕藥。同時，功效提高、副作用減少的新產品的出現，以及解決避孕方面未滿足的醫療需求的技術創新，正在為市場參與者創造利潤豐厚的成長機會。然而，市場成長受到替代計劃生育方法、避孕裝置以及與荷爾蒙藥物相關的副作用（如血栓、憂鬱症和體重變化）的阻礙。此外，社會恥辱和宗教保留繼續抑制一些地區對避孕藥的需求。

本研究的主要特點

• 本報告詳細分析了全球避孕藥具市場，並提供了以2023年為基準年的預測期（2024-2031年）的市場規模和年複合成長率（CAGR%）。
• 它還強調了各個細分市場的潛在收益成長機會，並說明了該市場有吸引力的投資提案矩陣。
• 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要市場參與者採取的競爭策略等的重要見解。
• 它根據公司亮點、產品系列、主要亮點、財務表現和策略等參數，介紹了全球避孕藥具市場的主要企業。
• 該報告的見解使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
• 全球避孕藥市場報告針對該行業的各個相關人員，如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
• 透過分析全球避孕藥具市場時所使用的各種策略矩陣，促進相關人員的決策。

第1章 研究目的與前提

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要
• Coherent Opportunity Map（COM）

第3章市場動態、法規及趨勢分析

• 市場動態
  • 促進因素：
• 避孕藥越來越受歡迎
• 政府加大力度促進計劃生育和避孕藥具的普及
  • 抑制因素
• 與錠劑相關的副作用
• 血栓和心血管疾病的風險
  • 機會
• 新興國家的需求不斷成長
• 選擇避孕藥具的女性人數增加
• 主要亮點
• 最近的趨勢
• PEST分析
• 波特的分析
• 最近的產品核准/發布
• 合併、收購和合作

第4章全球避孕市場 - 冠狀病毒 (COVID-19) 大流行的影響

• 新型冠狀病毒感染疾病（COVID-19）的流行病學
• 供需面分析
• 經濟影響

第5章全球避孕市場，依類型，2019-2031

• 複方避孕藥
• 單錠劑
• 多相錠劑
• 延長週期錠劑
• 荷爾蒙避孕藥
• 僅孕激素丸
• 事後緊急避孕藥
• levonorgestrel鹼
• 醋酸烏利司他鹼

第6章 全球避孕市場，依途徑，2019-2031

• 口服
• 可注射的
• 在子宮內
• 陰道
• 其他（補丁等）

第7章 全球避孕市場，依年齡段，2019-2031

• 青年
• 成人

第8章全球避孕藥市場，依通路，2019-2031

• 網路藥房
• 醫院藥房
• 零售藥房

第9章 全球避孕藥具市場（按地區），2019-2031

• 北美洲
• 美國
• 加拿大
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中部非洲
• 南非

第10章競爭格局

• 公司簡介
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck &Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

第11章 章節

• 參考
• 調查方法
• 關於出版商

Global contraceptive market was valued US$ 19.74 Bn in 2023 and is expected to reach US$ 52.41 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 13% from 2024 to 2031.

Figure 1. Global Contraceptive Market Share (%), By Region, 2024

Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.

Market Dynamics:

Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.

Key Features of the Study:

• This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
• It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market

Detailed Segmentation:

• Global Contraceptive Market, By Type
  • Combination Contraceptives
  • Monophasic pills
  • Multiphasic pills
  • Extended-cycle pills
  • Hormonal Contraceptives
  • Progestin-Only Pills
  • Emergency Contraceptives
  • Levonorgestrel-based
  • Ulipristal acetate-based
• Global Contraceptive Market, By Route of Administration
  • Oral
  • Injectable
  • Intrauterine
  • Vaginal
  • Others (Patches, etc.)
• Global Contraceptive Market, By Age Group
  • Adolescents
  • Adults
• Global Contraceptive Market, By Distribution Channel
  • Online Pharmacies
  • Hospital Pharmacies
  • Retail Pharmacies
• Global Contraceptive Market, By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Top Companies in the Global Contraceptive Market:
  • Bayer AG
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Route of Administration
  • Market Snippet, By Age Group
  • Market Snippet, By Distribution Channel
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers:
• Increasing popularity of contraceptive drugs
• Growing government initiatives for promoting access to family planning and contraceptives
  • Restraints
• Side effects associated with pills
• Risks of blood clots and cardiovascular diseases
  • Opportunities
• Growing demand in developing countries
• Growing female population opting for contraceptive drugs
• Key Highlights
• Recent Trends
• PEST Analysis
• PORTER's Analysis
• Recent Product Approvals/Launches
• Mergers, Acquisitions, and Collaborations

4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Contraceptive Market, By Type, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Combination Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Monophasic pills
• Multiphasic pills
• Extended-cycle pills
• Hormonal Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Progestin-Only Pills
• Emergency Contraceptives
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Levonorgestrel-based
• Ulipristal acetate-based

6. Global Contraceptive Market, By Route of Administration, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Oral
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Injectable
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Intrauterine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Vaginal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Others (Patches, etc.)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

7. Global Contraceptive Market, By Age Group, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Adolescents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Adults
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

8. Global Contraceptive Market, By Distribution Channel, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, 2020 - 2031
  • Segment Trends
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Bn)

9. Global Contraceptive Market, By Region, 2019-2031, (US$ Bn)

• Introduction
  • Market Share Analysis, By Region, 2024 and 2031 (%)
  • Y-o-Y Growth Analysis, For Region, 2020 - 2031
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• North Africa
• Central Africa
• South Africa

10. Competitive Landscape

• Company Profile
  • Bayer AG
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Strategies
  • Pfizer Inc.
  • Teva Pharmaceutical Industries
  • Merck & Co.
  • Janssen Pharmaceutical Companies
  • Allergan
  • Piramal Enterprises
  • Glenmark Pharmaceuticals
  • Lupin Pharmaceuticals
  • Mylan Pharmaceuticals
  • Mithra Pharmaceuticals
  • Gedeon Richter
  • HLL Lifecare
  • Cadila Healthcare
  • Organon
  • Other Prominent Players
• Analyst Views

11. Section

• References
• Research Methodology
• About us